4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: January 29, 2019
Period of Report: January 22, 2019
Accession Number: 0001645470-19-000006

View Document ↗ View on SEC.gov ↗